(Q70483492)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400608%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

title

Prevention of osteoporosis with nasal salmon calcitonin: effect of anti-salmon calcitonin antibody formation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400608%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

author name string

J Y Reginster

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400608%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

S Gaspar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400608%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

R Deroisy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400608%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

B Zegels

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400608%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

P Franchimont

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400608%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

publication date

1 September 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400608%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

11 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400608%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400608%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400608%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

page(s)

261-264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400608%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01623830

11 October 2019

exact match

0 references

cites work

Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study

1 reference

12 December 2020

Nasal calcitonin for treatment of established osteoporosis

1 reference

12 December 2020

In vivo long-term precision of spinal bone mass measurement by dual photon absorptiometry.

1 reference

12 December 2020

Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of Paget's disease

1 reference

12 December 2020

Effects of calcitonin on patients with Paget's disease, thyrotoxicosis, or hypercalcaemia

1 reference

12 December 2020

Amino acid sequence of salmon ultimobranchial calcitonin

1 reference

12 December 2020

Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance

1 reference

12 December 2020

Quantitative aspects of the reaction between insulin and insulin-binding antibody

1 reference

12 December 2020

Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects

1 reference

12 December 2020

An evaluation of antibodies and clinical resistance to salmon calcitonin

1 reference

12 December 2020

Effect of salcatonin given intranasally on early postmenopausal bone loss

1 reference

12 December 2020

Treatment of Paget's Disease with the Calcitonins*

1 reference

12 December 2020

Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.

1 reference

12 December 2020

Is there any place for salmon calcitonin in prevention of postmenopausal bone loss?

1 reference

12 December 2020

In vitro detection of neutralizing antibodies after treatment of Paget's disease of bone with nasal salmon calcitonin.

1 reference

12 December 2020

Long-term calcitonin therapy in postmenopausal osteoporosis

1 reference

12 December 2020

Effects of Prolonged Thyrocalcitonin Administration on Paget's Disease of Bone

1 reference

12 December 2020

Antibodies and clinical resistance to parathyroid hormone

1 reference

12 December 2020

Endogenous production of specific antibodies does not decrease hypocalcemic response to calcitonin in young rabbits

1 reference

12 December 2020

Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone

1 reference

12 December 2020

1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin

1 reference

12 December 2020

Down-regulation of rat kidney calcitonin receptors by salmon calcitonin infusion evidenced by autoradiography

1 reference

12 December 2020

Evidence for calcitonin--a new hormone from the parathyroid that lowers blood calcium

1 reference

12 December 2020

THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY

1 reference

12 December 2020

Treatment of Paget's disease of bone with synthetic human calcitonin: biochemical and roentgenologic changes

1 reference

12 December 2020

Development and significance of antibodies to salmon calcitonin in patients with Paget's disease on long-term treatment

1 reference

12 December 2020

Direct humoral control of parathyroid function in the dog

1 reference

12 December 2020

Measurement of bone mineral content (BMC) of the lumbar spine, I. Theory and application of a new two-dimensional dual-photon attenuation method

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01623830

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8400608%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

1 reference